{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:26:47Z","timestamp":1777364807777,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003125","name":"Suomen Kulttuurirahasto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["1726"],"award-info":[{"award-number":["1726"]}],"id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"HUS Helsinki University Hospital","doi-asserted-by":"publisher","award":["TYH 2012141"],"award-info":[{"award-number":["TYH 2012141"]}],"id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"HUS Helsinki University Hospital","doi-asserted-by":"publisher","award":["TYH 2013218"],"award-info":[{"award-number":["TYH 2013218"]}],"id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"HUS Helsinki University Hospital","doi-asserted-by":"publisher","award":["TYH 2014216"],"award-info":[{"award-number":["TYH 2014216"]}],"id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007797","name":"Helsingin Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.tmaid.2022.102403","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T12:44:51Z","timestamp":1658407491000},"page":"102403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Doxycycline as an antimalarial: Impact on travellers\u2019 diarrhoea and doxycycline resistance among various stool bacteria \u2013 Prospective study and literature review"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0004-1000","authenticated-orcid":false,"given":"Anu","family":"Kantele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sointu","family":"Mero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tinja","family":"L\u00e4\u00e4veri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2022.102403_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/cid\/ciu957","article-title":"Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae","volume":"60","author":"Kantele","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/cid\/civ333","article-title":"High rate of acquisition but short duration of carriage of multidrug-resistant enterobacteriaceae after travel to the tropics","volume":"61","author":"Ruppe","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cmi.2016.05.003","article-title":"Travel to Asia and traveller\u2019s diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum beta-lactamase-producing Enterobacteriaceae-a prospective cohort study","volume":"22","author":"Reuland","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.tmaid.2022.102403_bib4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1473-3099(16)30319-X","article-title":"Import and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study","volume":"17","author":"Arcilla","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12879-018-3245-z","article-title":"Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three european prospective studies","volume":"18","author":"L\u00e4\u00e4veri","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/jac\/30.5.693","article-title":"Ecological effects of short-term ciprofloxacin treatment of travellers' diarrhoea","volume":"30","author":"Wistrom","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tmaid.2022.102403_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tmaid.2017.01.003","article-title":"Fluoroquinolone antibiotic users select fluoroquinolone-resistant ESBL-producing Enterobacteriaceae (ESBL-PE) - data of a prospective traveller study","volume":"16","author":"Kantele","year":"2017","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib9","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.4269\/ajtmh.20-0241","article-title":"Doxycycline malaria prophylaxis impact on risk of travelers' diarrhea among international travelers","volume":"103","author":"Lago","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl 1","key":"10.1016\/j.tmaid.2022.102403_bib10","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1093\/clinids\/24.Supplement_1.S102","article-title":"Antimicrobial resistance in organisms causing diarrheal disease","volume":"24","author":"Sack","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2014.17006","article-title":"Traveler's diarrhea: a clinical review","volume":"313","author":"Steffen","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.tmaid.2022.102403_bib12","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4269\/ajtmh.1990.43.608","article-title":"A comparative study of gastrointestinal infections in United States soldiers receiving doxycycline or mefloquine for malaria prophylaxis","volume":"43","author":"Arthur","year":"1990","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2022.102403_bib13","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/jtm\/taw097","article-title":"Medications for the prevention and treatment of travellers' diarrhea","volume":"24","author":"Taylor","year":"2017","journal-title":"J Trav Med"},{"key":"10.1016\/j.tmaid.2022.102403_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40794-018-0074-4","article-title":"A review of antibiotic prophylaxis for traveler\u2019s diarrhea: past to present","volume":"4","author":"Diptyanusa","year":"2018","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"10.1016\/j.tmaid.2022.102403_bib15","unstructured":"The European committee on antimicrobial susceptibility testing. breakpoint tables for interpretation of MICs and zone diameters. version 6.0, 2016. http:\/\/www.eucast.org. Available at: http:\/\/www.eucast.org\/clinical_breakpoints\/. Accessed 17 July, 2016."},{"key":"10.1016\/j.tmaid.2022.102403_bib16","series-title":"Performance standards for antimicrobial Susceptibility Testing; twenty-fourth informational supplement","year":"2014"},{"key":"10.1016\/j.tmaid.2022.102403_bib17","author":"World Health Organization"},{"key":"10.1016\/j.tmaid.2022.102403_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tmaid.2018.01.006","article-title":"Travellers\u2019 diarrhoea: impact of TD definition and control group design on study results","author":"L\u00e4\u00e4veri","year":"2018","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/cid\/ciz182","article-title":"Despite predominance of Uropathogenic\/Extraintestinal pathotypes among travel-acquired extended-spectrum beta-lactamase-producing Escherichia coli, the most commonly associated clinical manifestation is travelers\u2019 diarrhea","volume":"70","author":"Kantele","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib20","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1056\/NEJM197804062981402","article-title":"Prophylactic doxycycline for travelers' diarrhea. results of a prospective double-blind study of peace corps volunteers in Kenya","volume":"298","author":"Sack","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2022.102403_bib21","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/0016-5085(79)90403-7","article-title":"Prophylactic doxycycline for travelers' diarrhea: results of a prospective double-blind study of peace corps volunteers in Morocco","volume":"76","author":"Sack","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tmaid.2022.102403_bib22","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/infdis\/143.4.598","article-title":"Biweekly prophylactic doxycycline for travelers' diarrhea","volume":"143","author":"Santosham","year":"1981","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib23","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0016-5085(83)80123-1","article-title":"Brief prophylaxis with doxycycline for the prevention of traveler's diarrhea","volume":"84","author":"Freeman","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tmaid.2022.102403_bib24","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/oxfordjournals.aje.a113962","article-title":"Prophylactic doxycycline for travelers' diarrhea in Thailand. further supportive evidence of Aeromonas hydrophila as an enteric pathogen","volume":"120","author":"Echeverria","year":"1984","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.tmaid.2022.102403_bib25","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4269\/ajtmh.1984.33.460","article-title":"Doxycycline prophylaxis of travelers' diarrhea in Honduras, an area where resistance to doxycycline is common among enterotoxigenic Escherichia coli","volume":"33","author":"Sack","year":"1984","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2022.102403_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1708-8305.2012.00607.x","article-title":"A cluster of acute diarrhea suspected to be cholera in French travelers in Haiti, December 2010","volume":"19","author":"Haus-Cheymol","year":"2012","journal-title":"J Trav Med"},{"key":"10.1016\/j.tmaid.2022.102403_bib27","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/imj.12179","article-title":"Association of doxycycline use with the development of gastroenteritis, irritable bowel syndrome and inflammatory bowel disease in Australians deployed abroad","volume":"43","author":"Lee","year":"2013","journal-title":"Intern Med J"},{"key":"10.1016\/j.tmaid.2022.102403_bib28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/jtm.12232","article-title":"Malaria chemoprophylaxis and self-reported impact on ability to work: mefloquine versus doxycycline","volume":"22","author":"Terrell","year":"2015","journal-title":"J Trav Med"},{"key":"10.1016\/j.tmaid.2022.102403_bib29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijmm.2014.12.001","article-title":"Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany","volume":"305","author":"Lubbert","year":"2015","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.tmaid.2022.102403_bib30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tmaid.2018.03.009","article-title":"Prevalence and risk factors for extended-spectrum beta-lactamase-producing- Enterobacteriaceae in French military and civilian travelers: a cross-sectional analysis","volume":"23","author":"Flateau","year":"2018","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib31","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cmi.2018.07.030","article-title":"High acquisition rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae among French military personnel on mission abroad, without evidence of inter-individual transmission","volume":"25","author":"Maataoui","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.tmaid.2022.102403_bib32","article-title":"Acquisition of multidrug-resistant bacteria and colistin resistance genes in French medical students on internships abroad","volume":"39","author":"Dao","year":"2020","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib33","doi-asserted-by":"crossref","first-page":"ofaa543","DOI":"10.1093\/ofid\/ofaa543","article-title":"Acquisition and long-term carriage of multidrug-resistant organisms in US international travelers","volume":"7","author":"Worby","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib34","doi-asserted-by":"crossref","first-page":":taab028","DOI":"10.1093\/jtm\/taab028","article-title":"Travel-associated multidrug-resistant organism acquisition and risk factors among US military personnel","volume":"28","author":"Buchek","year":"2021","journal-title":"J Trav Med"},{"key":"10.1016\/j.tmaid.2022.102403_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2021.102028","article-title":"Acquisition of antimicrobial resistance determinants in Enterobacterales by international travelers from a large urban setting in Brazil","volume":"41","author":"Tufic-Garutti","year":"2021","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ijantimicag.2014.01.026","article-title":"In vitro activity of rifaximin against clinical isolates of Escherichia coli and other enteropathogenic bacteria isolated from travellers returning to the UK","volume":"43","author":"Hopkins","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tmaid.2022.102403_bib37","doi-asserted-by":"crossref","first-page":":taab022","DOI":"10.1093\/jtm\/taab022","article-title":"Role of gut microbiota in travel-related acquisition of extended spectrum beta-lactamase-producing Enterobacteriaceae","volume":"28","author":"Peng","year":"2021","journal-title":"J Trav Med"},{"key":"10.1016\/j.tmaid.2022.102403_bib38","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/infdis\/143.6.767","article-title":"Travelers' diarrhea among American peace corps volunteers in rural Thailand","volume":"143","author":"Echeverria","year":"1981","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib39","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.1988.03410090077034","article-title":"Etiology of diarrhea among travelers and foreign residents in Nepal","volume":"260","author":"Taylor","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.tmaid.2022.102403_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/milmed\/156.1.27","article-title":"Travelers' diarrhea among United States military personnel during joint American-Egyptian armed forces exercises in Cairo, Egypt","volume":"156","author":"Haberberger","year":"1991","journal-title":"Mil Med"},{"key":"10.1016\/j.tmaid.2022.102403_bib41","doi-asserted-by":"crossref","first-page":"731","DOI":"10.7326\/0003-4819-114-9-731","article-title":"Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial","volume":"114","author":"Taylor","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmaid.2022.102403_bib42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00000441-199205000-00003","article-title":"Trimethoprim\/sulfamethoxazole remains active against enterotoxigenic Escherichia coli and Shigella species in Guadalajara, Mexico","volume":"303","author":"Bandres","year":"1992","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.tmaid.2022.102403_bib43","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1001\/jama.1992.03480140058033","article-title":"Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico","volume":"267","author":"DuPont","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.tmaid.2022.102403_bib44","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1128\/AAC.44.6.1731-1733.2000","article-title":"Quinolone resistance in enterotoxigenic Escherichia coli causing diarrhea in travelers to India in comparison with other geographical areas","volume":"44","author":"Vila","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tmaid.2022.102403_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1201-9712(03)90040-3","article-title":"Phenotypic diversity of enterotoxigenic escherichia coli (ETEC) isolated from cases of travelers' diarrhea in Kenya","volume":"7","author":"Shaheen","year":"2003","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/jac\/dkp178","article-title":"Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller's diarrhoea","volume":"64","author":"Mendez Arancibia","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tmaid.2022.102403_bib47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.diagmicrobio.2009.10.002","article-title":"The epidemiology of travelers' diarrhea in Incirlik, Turkey: a region with a predominance of heat-stabile toxin producing enterotoxigenic Escherichia coli","volume":"66","author":"Porter","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib48","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1128\/AAC.00739-10","article-title":"In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008","volume":"55","author":"Ouyang-Latimer","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tmaid.2022.102403_bib49","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.4269\/ajtmh.16-0633","article-title":"Case-case analysis using 7 years of travelers' diarrhea surveillance data: preventive and travel medicine applications in Cusco, Peru","volume":"96","author":"Jennings","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2022.102403_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40794-017-0056-y","article-title":"Antibiotic resistance in Campylobacter and other diarrheal pathogens isolated from US military personnel deployed to Thailand in 2002-2004: a case-control study","volume":"3","author":"Mason","year":"2017","journal-title":"Trop Dis Travel Med Vac"},{"key":"10.1016\/j.tmaid.2022.102403_bib51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13756-018-0377-2","article-title":"Extended-spectrum beta-lactamase prevalence and virulence factor characterization of enterotoxigenic Escherichia coli responsible for acute diarrhea in Nepal from 2001 to 2016","volume":"7","author":"Margulieux","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.tmaid.2022.102403_bib52","doi-asserted-by":"crossref","first-page":":e01745","DOI":"10.1128\/AAC.01745-18","article-title":"Emergence of resistance to quinolones and beta-lactam antibiotics in enteroaggregative and enterotoxigenic Escherichia coli causing traveler\u2019s diarrhea","volume":"63","author":"Guiral","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tmaid.2022.102403_bib53","doi-asserted-by":"crossref","first-page":":taz054","DOI":"10.1093\/jtm\/taz054","article-title":"Traveler\u2019s diarrhea in Nepal-changes in etiology and antimicrobial resistance","volume":"26","author":"Murphy","year":"2019","journal-title":"J Trav Med"},{"key":"10.1016\/j.tmaid.2022.102403_bib54","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1099\/jmm.0.001214","article-title":"Antimicrobial resistance profiles of diarrhoeagenic Escherichia coli isolated from travellers returning to the UK, 2015-2017","volume":"69","author":"Boxall","year":"2020","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.tmaid.2022.102403_bib55","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/infdis\/165.3.557","article-title":"Treatment of traveler's diarrhea with ciprofloxacin and loperamide","volume":"165","author":"Petruccelli","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib56","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/jac\/dkg489","article-title":"Multidrug resistance in Campylobacter jejuni strains collected from Finnish patients during 1995-2000","volume":"52","author":"Hakanen","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tmaid.2022.102403_bib57","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijfoodmicro.2004.03.017","article-title":"Species identification by genotyping and determination of antibiotic resistance in Campylobacter jejuni and Campylobacter coli from humans and chickens in Sweden","volume":"96","author":"Ronner","year":"2004","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.tmaid.2022.102403_bib58","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0463.2007.apm_567.x","article-title":"Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea","volume":"115","author":"Ruiz","year":"2007","journal-title":"APMIS"},{"key":"10.1016\/j.tmaid.2022.102403_bib59","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijfoodmicro.2009.03.006","article-title":"Trends in occurrence of antimicrobial resistance in campylobacter jejuni isolates from broiler chickens, broiler chicken meat, and human domestically acquired cases and travel associated cases in Denmark","volume":"131","author":"Skjot-Rasmussen","year":"2009","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.tmaid.2022.102403_bib60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1757-4749-2-15","article-title":"PFGE, lior serotype, and antimicrobial resistance patterns among campylobacter jejuni isolated from travelers and US military personnel with acute diarrhea in Thailand, 1998-2003","volume":"2","author":"Serichantalergs","year":"2010","journal-title":"Gut Pathog"},{"key":"10.1016\/j.tmaid.2022.102403_bib61","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s10096-017-3032-6","article-title":"Antibiotic susceptibility profiles among campylobacter isolates obtained from international travelers between 2007 and 2014","volume":"36","author":"Post","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib62","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1185\/03007998509109608","article-title":"Changes during travel in the composition and antibiotic resistance pattern of the intestinal enterobacteriaceae flora: results from a study of mecillinam prophylaxis against travellers' diarrhoea","volume":"9","author":"Gaarslev","year":"1985","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.tmaid.2022.102403_bib63","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/20.4.563","article-title":"Norfloxacin versus placebo for prophylaxis against travellers' diarrhoea","volume":"20","author":"Wistr\u00f6m","year":"1987","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tmaid.2022.102403_bib64","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/jac\/23.6.905","article-title":"Short-term self-treatment of travellers' diarrhoea with norfloxacin: a placebo-controlled study","volume":"23","author":"Wistr\u00f6m","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tmaid.2022.102403_bib65","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/BF01963753","article-title":"Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea","volume":"8","author":"Rademaker","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib66","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1080\/00365540110076589","article-title":"Emergence of trimethoprim-resistant escherichia coli in healthy persons in the absence of prophylactic or therapeutic antibiotics during travel to guadalajara, Mexico","volume":"33","author":"Huang","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib67","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1086\/338834","article-title":"Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (mombasa), India (Goa), or Jamaica (montego bay)","volume":"185","author":"Jiang","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102403_bib68","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40794-016-0020-2","article-title":"Antimicrobial resistance acquisition after international travel in U.S. travelers","volume":"2","author":"Blyth","year":"2016","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"10.1016\/j.tmaid.2022.102403_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/srep31964","article-title":"The role of doxycycline in the therapy of multidrug-resistant E. coli - an in vitro study","volume":"6","author":"Lai","year":"2016","journal-title":"Sci Rep"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893922001491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893922001491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:36:05Z","timestamp":1762547765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893922001491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":68,"alternative-id":["S1477893922001491"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2022.102403","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Doxycycline as an antimalarial: Impact on travellers\u2019 diarrhoea and doxycycline resistance among various stool bacteria \u2013 Prospective study and literature review","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2022.102403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102403"}}